Symptoms And Symptoms Of Asthma

Televised drug ads have helped to update patients on the positives of pharmaceuticals. The Direct-to-Consumer (DTC) drug ads inform people about medical conditions and the treatments that come with those conditions. As stated by this article, “44% of patients…said that DTC prescription drug ads helped educate them about drugs, medical conditions, and treatments” (“Should Prescription Drugs” 2). For most patients, they are unaware of what is inside of their medications and what the risks are. With prescription drug ads, they allow the uninformed patients to become informed by

Marketing products, services, or even charities to the public has become a very powerful force in our world. Millions of dollars are spent on advertising each year with the goal of increasing revenue for the business or raising awareness of an organization to the public. Pharmaceutical companies bring products to the markets that are intended to help people live better lives. Advertising is a relatively new phenomenon for pharmaceutical companies in the United States. “In 1985, the U.S. Food and Drug Administration (FDA), which has the responsibility for safety regulations governing drugs, passed a ruling that allowed direct market to consumers on the condition that a great deal of warning information was provided

There is a significant correlation between an increase in direct-to-consumer pharmaceutical advertisements and an increase in prescriptions. The critics who are opposed to direct-to-pharmaceutical advertisements suggest that more advertising leads to more requests and more prescriptions of certain medications. They also claim that the publications of such advertisements may eventually blur the distinction between patient and consumer if we are not careful. Physicians have reported that most patients who are knowledgeable on a DTC advertised pharmaceutical

Direct-to-Consumer Advertisements have both good and bad aspects to it, as discussed previously. The question that comes to mind is whether or not the beneficial sides outweigh the bad ones in the eyes of consumers, physicians, and other healthcare providers. According to Kannan et al (1), 97 physicians of the 155 surveyed, reported that patients asked about a drug advertisement they had seen. Of those 97 physicians, 51 of them agreed that the drugs they questioned about were not useful for their condition. Only 51 physicians of the 155 thought that this would help strengthen the relationship between them and their patients. Rather, 82 doctors thought it would hurt the relationships. This could be due in part that the doctor would be declining

RESEARCH PURPOSE: One of the triumphs of the biomedical revolution of the past 30 years is the development of a large and growing pharmacopeia of therapeutic drugs. Used appropriately, these drugs enhance patient’s quality of life, improve functional capacity and sometimes extend life. However in the aggregate, prescription drugs represent a substantial health care expenditure. To ensure steady demand for their products, pharmaceutical manufacturers have traditionally deployed large armies of sales representatives marketing their ways to physician (1). Lately the pharmaceutical industry had altered its marketing strategy by increasing its reliance on direct- to- consumer (DTC) advertising. The amount to money spent on DTC advertising has risen from 600 million to 8 billion in the last decade (2). Almost 145 million U.S. adults look up for health information online in 2008. Views on DTC ads (DTCA) center on three effects: cost, communication, and health of the public. Critics claim that DTCA raises health care costs by stimulating consumers to demand newer, more expensive drugs, often with high profit margins (3, 4). The pharmaceutical industry rejects arguments that DTCA is inflationary, and while not denying the profit motive, it points out that DTCA serves a patient education function. The industry’s argument is that patients are highly motivated to

There are various controversies surrounding Direct-to-consumer prescription advertisements impact on health, including its inference in the doctor-patient relationship, as well as its influence on consumers lifestyle.

Pharmaceutical drug companies spent nearly $4.6 billion more on advertising aimed directly at consumers in 2009 than in 1995. This dramatic increase is largely due to the Food and Drug Administration’s (FDA) decision to reform their standards regarding direct-to-consumer (DTC) advertising. Prior to the changes that occurred in 1997, all DTC advertisements had to include a brief summary of the drug’s warnings, precautions, adverse effects, and situations in which the drug should not be used. In place of the brief summary, the FDA’s new regulations introduced two new criteria: the major statements clause and the adequate provision clause (Ventola). Instead of a brief summary, the major statements clause requires advertisements to disclose only

Direct-to-consumer (DTC) marketing of pharmaceuticals has grown increasingly in the past decade. The American public views prescription drug advertising for a wide range of medical conditions, including high cholesterol, depression, allergies, and erectile dysfunction. The Federal Food and Drug Administration (FDA) regulates the content of these advertisements. Critics also have taken the position that the advertisements garner unearned trust from the public, are misleading, and promote unnecessary use of prescription drugs for common problems associated with aging. Proponents counter that DTC ads help eliminate stigmas associated with certain medical conditions, give patients an active role in their health care management, and

Climate change is now a widely-accepted fact. We know that the earth is changing, and not necessarily for the better. Air quality is worsening, temperatures are increasing and fluctuating, greenhouse gases are rampant, and plants are changing their behavior. All of these add up to increased and worsening cases of asthma in children. Children are already more prone to sickness and disease, and climate change is only making it worse. According to the World Health Organization, 80% of the climate change health burden falls on children less than 5 years old. How tough is climate change for kids with asthma? There are several issues that climate change creates for young asthmatics.

The hospital setting is a confusing and stressful environment for everyone, but especially to children who are admitted because of a chronic illness. When the words “pediatric chronic illness” is said, most people just think of the different types of cancers that children endure. Such as leukemia, which is a widely known type of pediatric cancer. But it is important to keep in mind the many other types of chronic illnesses that children may be experiencing. Haymon, Mahon, Turner, a group of professional medical experts who all carry a PhD under their belt and other certifications, gathered together and wrote a book focusing on five chronic illnesses examined in children, which are: pediatric asthma, Type 1 diabetes, juvenile idiopathic arthritis,

Caleb is a 10-year-old male here today with his mother with complaints of a cold and a sore throat.

The proof is mounting that bronchial asthma| instead of being a single disease is a set of sickness groups with particular causes partly overlapping clinical and physiological characteristics. The phenotypic heterogeneity amongst asthmatic patients is obvious at more than one level along with the degree of airway obstruction, a variety of airway inflammation, the presence of airway remodeling, and reaction to treatment(33). In spite of the fact that asthma has for quite some time been viewed as a heterogeneous disease, attempts to characterize subgroups of asthma have been restricted. As of late, both clinical and statistical methodologies have been used to better consolidation clinical qualities, science, and genetics(34). A phenotype is described

A study of over 1000 physicians found 72% saw direct-to-consumer advertising as having a positive impact in encouraging patient compliance of treatment or advice.(Murray) A study conducted by a pharmaceutical company from found that the percentage of patients with diabetes, depression, elevated cholesterol levels, arthritis, or allergies who continued with therapy after six months was substantially higher when the patient asked for a medicine after being prompted by direct-to-consumer advertising than when the patient was given a prescription for a medicine without such prompting.

For most people hearing or seeing the advertisement first hand, has become commonplace. Direct to Consumer (DTC) advertising is one way pharmaceutical drug companies get their message to just about everyone, not to mention consumers. Whether direct to consumer advertisement harms or helps is unknown, since the effectiveness of the advertisement is also unknown. Though, regulated by the Food and Drug Administration (FDA), the advertisement of drugs is largely left up to the consumer to decide if they should believe the information presented is, first off reliable and secondly, if they should seek further information. That information, usually comes from the knowledge of a physician. However, with information at their fingertips through online sources, some delve in on their own efforts. In this report, DTC advertisement is questioned: of its effectiveness and of its usefulness. The reasons why both doctors and consumer think DTC advertisement is available and should this form of advertisement continue to be allowed in the public?

One of the key manners in which direct-to-physician advertising of pharmaceuticals can lead to health promotion is in the reduction of malpractice on the part of physicians when it comes to the administering of pharmaceuticals. It is of course the primarily (and ultimately, solely) the physicians' responsibility to ensure the proper and effective use of pharmaceutical products, just as it is their responsibility to ensure that all care practices and interventions are in the best interests of the patient. Pharmaceutical companies have this goal and this responsibility as well, however, and they can be instrumental in making sure that true best interests are served with current knowledge of best practices and new potentials. As advertising is ultimately the provision of information, it can be seen that the direct advertising of pharmaceuticals to physicians can provide more comprehensive, detailed, and current information regarding new products, new uses, and the risks and benefits of specific pharmaceutical agents. The direct advertising constitutes an information-sharing relationship, and arming physicians with better information can only serve to assist them in their quest to achieve the best results for their patients (Schwartz et al, 2009).